All patients |
n
|
20 |
31 |
37 |
T2DM, n
|
15/20 |
2/31 |
8/37 |
Median length of hospitalisation, days (IQR) |
7.0 (5.2–19.5) |
5 (1.9–8.2) |
4.9 (2.3–11.4) |
Median age, years (IQR) |
59.8 (43.0–69.0) |
50.9 (33.3–60.9) |
31 (24.4–54.2) |
Male gender, n
|
14/20 |
19/31 |
22/37 |
Median weight, kg (IQR) |
76.2 (51.7–86.1) |
65.4 (58.9–70.7) |
63 (55.1–75.0) |
Median height, m (IQR) |
1.73 (1.7–1.8) |
1.6 (1.6–1.7) |
1.7 (1.6–1.8) |
SGLT2 inhibitors, n
|
6/20 |
1/31 |
0/37 |
ACEi/ARB, n
|
6/20 |
1/31 |
1/37 |
ITU admission, n
|
6/20 |
4/31 |
0/37 |
Deaths, n
|
4/20 |
1/31 |
0/37 |
Episodes of hypokalaemia, n (IQR) |
0 (0–0) |
1 (0–4) |
0 (0–0) |
Episodes of hyperkalaemia, n (IQR) |
0 (0–1) |
0 (0–1) |
0 (0–0) |
T1DM |
n
|
5 |
29 |
29 |
Median length of hospitalisation, days (IQR) |
4.5 (4.3–4.8) |
5 (1.9–8.0) |
3.6 (2.1–7.8) |
Median age, years (IQR) |
30.9 (27.0–45.0) |
47.4 (33.2–58.9) |
26.5 (23.9–49.8) |
Male gender, n
|
2/5 |
17/29 |
16/29 |
Median weight, kg (IQR) |
67.9 (49.4–86.7) |
65.7 (58.5–71.1) |
60.7 (55.1–71.1) |
Median height, m (IQR) |
1.7 (1.7–1.8) |
1.6 (1.6–1.7) |
1.7 (1.6–1.7) |
SGLT2 inhibitors, n
|
0/5 |
0/29 |
0/29 |
ACEi/ARB, n
|
0/5 |
1/29 |
0/29 |
ITU admission, n
|
2/5 |
4/29 |
0/29 |
Deaths, n
|
0/5 |
1/29 |
0/29 |
Episodes of hypokalaemia, n (IQR) |
0 (0–2) |
0.5 (0–3) |
0 (0–0) |
Episodes of hyperkalaemia, n (IQR) |
1 (0–1) |
0 (0–0.75) |
0 (0–0) |
T2DM |
n
|
15 |
2 |
8 |
Median length of hospitalisation, days (IQR) |
10.0 (6.0–20.0) |
10.8 (7.4–14.2) |
11.2 (8.1–18.7) |
Median age, years (IQR) |
63.0 (58.8–75.0) |
72.7 (70.9–74.6) |
58.0 (50.5–70.4) |
Male gender, n
|
12/15 |
2/2 |
6/8 |
Median weight, kg (IQR) |
76.2 (64.8–83.4) |
60.0 (60.0–60.0) |
98.0 (59.4–114.0) |
Median height, m (IQR) |
1.7 (1.7–1.7) |
1.7 (1.7–1.7) |
1.8 (1.7–1.8) |
SGLT2 inhibitors, n
|
6/15 |
1/2 |
0/8 |
ACEi/ARB, n
|
6/15 |
0/2 |
1/8 |
ITU admission, n
|
4/15 |
0/2 |
1/8 |
Deaths, n
|
4/15 |
0/2 |
0/8 |
Episodes of hypokalaemia, n (IQR) |
0 (0–0) |
2.5 (1–4) |
0 (0–0.75) |
Episodes of hyperkalaemia, n (IQR) |
0 (0–1) |
0 (0–0) |
0 (0–0) |